Form 4: TransMedics Group Officer Nicholas Corcoran Reports Acquisition of Restricted Stock Units and Stock Options
SEC Form 4 Filing
Nicholas Corcoran, SVP of Supply Chain and Operations at TransMedics Group, reported the acquisition of restricted stock units and stock options.
Summary
- On February 24, 2025, Nicholas Corcoran, SVP of Supply Chain and Operations at TransMedics Group, Inc., reported the acquisition of 12,676 restricted stock units (RSUs) and 19,079 stock options.
- Each RSU represents a contingent right to receive one share of TransMedics Group's common stock.
- The stock options have an exercise price of $77.12 and vest monthly from February 24, 2025, until fully vested on February 24, 2029, subject to continued service.
- Following these transactions, Corcoran directly owns 33,781 shares of common stock and 19,079 stock options.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects an executive increasing their stake in the company, which is generally seen as a positive sign. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.
Positives
- The acquisition of RSUs and stock options suggests confidence in the company's future performance from the executive.
Future Outlook
The vesting schedule of the stock options indicates a long-term commitment from the executive to the company's success.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in Nicholas Corcoran's beneficial ownership of TransMedics Group's securities.
Stakeholder Impact
- The reported transactions provide transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 2025-01-09 | Date of Limited Power of Attorney execution by Nicholas Corcoran. |
| 2025-02-24 | Date of transaction: Acquisition of restricted stock units and stock options. |
| 2025-02-24 | Start date for monthly vesting of stock options. |
| 2029-02-24 | Date when stock options are fully vested. |
| 2035-02-24 | Expiration date of the stock options. |
| 2025-02-26 | Date of signature of the report by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.